Navigation Links
Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai

SHANGHAI, June 25 /PRNewswire-Asia/ -- In the afternoon of June 22, Shanghai Pudong Customs, Pudong International Airport Customs and Zhangjiang Group Co. held ceremony in the Zhangjiang Hi-Tech Park to initiate the Express Customs Clearance for 3 biopharmaceutical R&D outsourcing (CRO) companies. The selected CRO companies are Sundia MediTech, Huiyuan Biotechnology, and Frontage Laboratories from Zhangjiang Hi-Tech Park. This event marked the formal start of the trial operation of a new customs clearance model for CRO companies in Zhangjiang.

Sundia's Chairman and CEO Dr. Xiaochuan Wang and Executive VP Dr. Xiongwei Shi attended the ceremony with representatives from many biopharmaceutical companies. Ms. Liu Zhengyi, Deputy Director of the Pudong District Government was at the ceremony to extend her congratulations. Mr. Ma Yan, Director of Pudong Customs, Mr. Shi Wenyan, Director of Pudong International Airport Customs, and Mr. Liu Xiaolong, Executive VP of Zhangjiang Group Co. signed a Letter of Intention for Customs' Cooperation to Support Development of Zhangjiang Pharma Valley.

Earlier this year, China Central Government adopted a policy to "encourage service outsourcing industry". High level officials, including Premier Wen Jiabao called on strong support to this industry. As a key part of service outsourcing, CRO companies in Zhangjiang get more and more attention. With growing innovative capability and national influence, the reputation and strength of Zhangjiang Pharma Valley has become more prominent as it turns into the most developed CRO base in China.

With the rapid growth of the CRO industry, customs clearance efficiency becomes a significant bottleneck for CRO companies due to high import/export volume, numerous categories, new products, strict storage requirements, etc. Fast customs clearance has become the most pressing need of CRO companies. Therefore, Shanghai Pudong Customs and Pudong International Airport Customs jointly proposed selecting some CRO companies in the Zhangjiang High-Tech Park for trial operation of express clearance, which implements various measures including "declaration in advance and clearance upon goods arrival", "archiving system of classification and price review", "assured clearance" and "24-hour appointed clearance", to establish a new customs clearance model for CRO companies and achieve a balance between strict supervision and efficient operation.

The first 3 CRO companies were recommended by Zhangjiang Park to governing customs after considering various factors such as company reputation, track record, size, and status. Then they were selected by customs after strict review and screening regarding the companies' credibility, internal management system, laboratory qualification and customs clearance record.

At present, customs is gradually putting more effort into the trial operation. The next step will be expanding the operation within Zhangjiang Park on the basis of previous experience so that more companies can benefit from the new measures, and better service can be provided to help the growth of CRO industry.

"This is really a big step by Chinese customs to support the growth of Sundia and other CRO companies. We are encouraged by this and many other measures the Chinese Government put together to help the development of CRO industry," commented by Dr. Xiaochuan Wang, Sundia's Chairman and CEO.

About Sundia MediTech Company:

Sundia is a leading integrated pharmaceutical contract research organization (CRO) company based in Shanghai, China. Sundia provides services to biotech and pharmaceutical companies worldwide, ranging from early hit screening, biological service, lead optimization, DMPK, candidate preclinical development, formulation development, API manufacture, and regulatory submission. For more information, please visit .

SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Sundias Animal Facility Passed Client and Government Inspection
2. Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List
3. Sundia MediTech and Xcovery Announce Big Success in Drug Discovery
4. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
5. CEL-SCI Files Patent Application to Support Companys Treatment for More Virulent Strain of H1N1 Swine and Other Influenza Viruses
6. Lytix Biopharma and KAEL-GemVax Announce Joint Clinical Trial to Combine LTX-315 and GV1001 Cancer Immunotherapy
7. NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces
8. Modigene Shareholders Approve Company Name Change and Other Proposals at Annual Meeting
9. AEterna Zentaris Discloses Preliminary Phase 2 Trial Results for Perifosine in Combination with Radiotherapy for Non-Small Cell Lung Cancer
10. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
Post Your Comments:
(Date:10/13/2015)... -- the United States , ... about 14% of all new cases of kidney cancer.   ... and Europe .  PRCC represents about ... Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces that ... (publ) ("AstraZeneca") have completed enrolment in a global Phase II study ...
(Date:10/12/2015)... 2015  Rebiotix Inc. today announced that U.S. ... lead Microbiota Restoration Therapy (MRT) RBX2660 as a ... Clostridium difficile (C diff) infection, a challenging ... deaths in the U.S. annually. 1 Rebiotix ... founded to revolutionize the treatment of debilitating GI ...
(Date:10/12/2015)... , October 12, 2015 ... Dario™ Diabetes Management Solution, today announced its Medical Director, ... case study at MobiHealth,s 5th EAI International Conference ... "Transforming healthcare through innovations in mobile and wireless technologies," ... England from October 14 - 16, 2015. ...
(Date:10/12/2015)... ... October 12, 2015 , ... LifeTrak , a leader in consumer ... the world’s first amphibious fitness tracker that seeks to meet the needs of multi-sport ... heart rate monitoring both in water and on land, making it the ...
Breaking Biology Technology:
(Date:9/28/2015)... 28, 2015  The monitoring of vital signs, ... temperature, is an essential component of patient assessment. ... deterioration in a patient,s condition. However, in general ... typically taken during routine observation rounds only once ... deteriorates between these observation rounds, the warning signs ...
(Date:9/26/2015)... 26th, 2015  Results of a TactioRPM pilot ... today at the Stanford Medicine X Conference. In ... Dashboards, Connected Health Devices and Pharmacogenomics", Roger ... will explain how senior patients equipped with connected ... pharmacist via the TactioRPM remote patient monitoring platform ...
(Date:9/10/2015)... , Sept. 10, 2015 Report ... New Study Reveals Selling Opportunities and Revenue Prospects ... the future of biologics, especially new drug classes? ... will stay ahead with exclusive market data and ... explore trends, developments, results, opportunities and sales predictions. ...
Breaking Biology News(10 mins):